摘要
目的:探讨耳内镜下鼓膜穿刺治疗70例分泌性中耳炎的临床观察。方法:回顾性分析2010年12月-2012年12月在我院接受治疗的120例分泌性中耳炎患者,将所有患者随机分成两组:试验组和对照组,每组患者为60例,对照组给予鼓膜穿刺联合盐酸氨溴索,试验组给予鼓膜穿刺联合地塞米松与α-糜蛋白酶,密切观察两组患者的临床效果。结果:(1)试验组的总有效率(90.0%)明显高于对照组的总有效率(78.3%)(P〈0.05),两组间的差异具有统计学意义;(2)两组分泌性中耳炎患者经过一个疗程的治疗之后,试验组耳聋、耳鸣、耳听力下降以及耳闷塞感等不良反应的发生率(5.0%)均低于对照组的不良反应发生率(13.3%)。结论:耳内镜下鼓膜穿刺联合地塞米松与α-糜蛋白酶具有药效作用快、不良反应少等优点,在治疗分泌性中耳炎中具有较高的安全性和有效性,大幅度减轻患者的痛苦,提高患者的生活质量。
Objective:To study auripucture with otic endoscope in treating 70 cases of patients with secretory otitis media. Methods:During the period December 2010 to December 2012,120 cases of otitis media with effusion in patients treated in our hospital,all patients were randomly divided into two groups:the experimental group and the control group,60 cases in each group of patients,the control group was given the tympanic membrane puncture joint ambroxol hydrochloride,the study group received a tympanic membrane puncture in combination with dexamethasone andα-chymotrypsin,close observation of twothe group of patients with clinical effect.Results:(1)The test group total efficiency (90.0%) was significantly higher than the total efficiency (78.3%) (P〈0.05),the gap between the two groups is statistically significant;(2)The two groups of patients with secretory otitis media after the treatment, the test group of deafness,tinnitus,ear hearing loss,ear choking flu incidence of adverse reactions (5.0%) were lower than the control group,the incidence of adverse reactions (13.3%).Conclusion:Microscope in the ear,the eardrum puncture the joint dexamethasone withα-chymotrypsin the fast Efficacyt fewer adverse reactions, higher safety and efficacy in the treatment of secretory otitis media,significantly reduce patientpain and improve the patient's quality of life.
出处
《中国医药导刊》
2013年第10期1568-1569,共2页
Chinese Journal of Medicinal Guide
关键词
耳内镜
鼓膜穿刺
分泌性中耳炎
Otic endoscope
Puncture of tympanum
Secretory otitis media